4-Quinolinecarboxamide, 3-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]-
| Title | Journal |
|---|---|
| Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. | European journal of medicinal chemistry 20130501 |
| Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats. | British journal of pharmacology 20101201 |
| NK-3 receptor antagonism prevents behavioral sensitization to cocaine: a role of glycogen synthase kinase-3 in the nucleus accumbens. | Journal of neurochemistry 20101101 |
| A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle. | Proceedings of the National Academy of Sciences of the United States of America 20100223 |
| Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. | Nature chemical biology 20091001 |
| Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity. | Neuropharmacology 20090901 |
| New quinoline NK3 receptor antagonists with CNS activity. | Bioorganic & medicinal chemistry letters 20090201 |
| The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils. | European journal of pharmacology 20081214 |
| cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. | Journal of medicinal chemistry 20081127 |
| Localization and function of NK(3) subtype tachykinin receptors of layer V pyramidal neurons of the guinea-pig medial prefrontal cortex. | Neuroscience 20081028 |
| Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats. | European journal of pharmacology 20080820 |
| Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease. | Neuropharmacology 20080601 |
| Functionalization through lithiation of (S)-N-(1-phenylpropyl)-2-phenylquinoline-4-carboxamide. Application to the labeling with carbon-11 of NK-3 receptor antagonist SB 222200. | The Journal of organic chemistry 20070316 |
| Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition. | Molecular pharmacology 20070301 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret. | Neuroscience letters 20050307 |
| Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20041110 |
| Eledoisin and Kassinin, but not Enterokassinin, stimulate ion transport in frog skin. | Peptides 20041101 |
| Role of tachykinin receptors in the central processing of afferent input from the acid-threatened rat stomach. | Regulatory peptides 20011215 |
| Contribution of NK3 tachykinin receptors to propulsion in the rabbit isolated distal colon. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20010601 |
| Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor. | European journal of pharmacology 20010216 |
| Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. | The Journal of pharmacology and experimental therapeutics 20001001 |
| 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. | Journal of medicinal chemistry 19960607 |